Product Details for NDA 020489
ANDRODERM (TESTOSTERONE)
2MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
2.5MG/24HR
Marketing Status: Discontinued
4MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
5MG/24HR
Marketing Status: Discontinued
2MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: TESTOSTERONE
Proprietary Name: ANDRODERM
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 2MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020489
Product Number: 003
Approval Date: Oct 20, 2011
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
ANDRODERM (TESTOSTERONE)
Proprietary Name: ANDRODERM
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 2MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020489
Product Number: 003
Approval Date: Oct 20, 2011
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
2.5MG/24HR
Marketing Status: Discontinued
Active Ingredient: TESTOSTERONE
Proprietary Name: ANDRODERM
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 2.5MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020489
Product Number: 001
Approval Date: Sep 29, 1995
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
ANDRODERM (TESTOSTERONE)
Proprietary Name: ANDRODERM
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 2.5MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020489
Product Number: 001
Approval Date: Sep 29, 1995
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
4MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: TESTOSTERONE
Proprietary Name: ANDRODERM
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 4MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020489
Product Number: 004
Approval Date: Oct 20, 2011
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
ANDRODERM (TESTOSTERONE)
Proprietary Name: ANDRODERM
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 4MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020489
Product Number: 004
Approval Date: Oct 20, 2011
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
5MG/24HR
Marketing Status: Discontinued
Active Ingredient: TESTOSTERONE
Proprietary Name: ANDRODERM
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 5MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020489
Product Number: 002
Approval Date: May 2, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: ANDRODERM
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 5MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020489
Product Number: 002
Approval Date: May 2, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information